Showing 1,461 - 1,480 results of 10,572 for search '"Tumor"', query time: 0.11s Refine Results
  1. 1461
  2. 1462

    Feline mastocytoma. Case report by G. A. Delgado-López, C. A. Moreno-Babilonia

    Published 2020-01-01
    Subjects: “…tumores cutáneos…”
    Get full text
    Article
  3. 1463

    Correspondencia entre diagnóstico clínico e histopatológico de los tumores de los anexos oculares by Armando Rafael Milanés Armengol, Mariela Curbelo Gómez, Katia Molina Castellanos, María Adela Llull Tombo, Marisleydis Landestoy Borrell, Marla Milanés Molina

    Published 2015-11-01
    “…<strong>Fundamento:</strong> los tumores de los anexos oculares constituyen una causa frecuente de visita a la consulta de Oftalmología. …”
    Get full text
    Article
  4. 1464

    Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome by Brian Z Ring, Catherine T. Cronister, Huijun Z. Ring, Douglas T. Ross, Robert S. Seitz

    Published 2025-01-01
    “…Abstract Understanding the dynamic tumor immune microenvironment (TIME) is important in guiding immunotherapy. …”
    Get full text
    Article
  5. 1465
  6. 1466
  7. 1467
  8. 1468

    Comparison of Amino Acid Positron Emission Tomographic Radiotracers for Molecular Imaging of Primary and Metastatic Brain Tumors by Csaba Juhász, Shalini Dwivedi, David O. Kamson, Sharon K. Michelhaugh, Sandeep Mittal

    Published 2014-08-01
    “…Positron emission tomography (PET) is an imaging technology that can detect and characterize tumors based on their molecular and biochemical properties, such as altered glucose, nucleoside, or amino acid metabolism. …”
    Get full text
    Article
  9. 1469
  10. 1470

    Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer by Yina Gao, Yangyang Dong, Yingxu Zhou, Gongyan Chen, Xuan Hong, Qingyuan Zhang

    Published 2022-01-01
    “…Patient stratification by tumor location should inform the therapeutic strategy. …”
    Get full text
    Article
  11. 1471

    Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors by Romain Pacaud, Scott Thomas, Sibapriya Chaudhuri, Ann Lazar, Luika A. Timmerman, Pamela N. Munster

    Published 2025-01-01
    “…Abstract Background Poly (ADP-Ribose) polymerase inhibitors are approved for treatment of tumors with BRCA1/2 and other homologous recombination repair (HRR) mutations. …”
    Get full text
    Article
  12. 1472

    Intelligence analysis of drug nanoparticles delivery efficiency to cancer tumor sites using machine learning models by Wael A. Mahdi, Adel Alhowyan, Ahmad J. Obaidullah

    Published 2025-01-01
    “…The dataset includes both categorical and numerical variables related to nanoparticle properties, with a focus on their distribution across organs such as the tumor, heart, liver, spleen, lung, and kidney tissues. …”
    Get full text
    Article
  13. 1473

    Filters Effect on Image Quality of 177Lu-DOTATATE SPECT Images for Neuro-Endocrine Tumors Scanning by Hussein Dakhil, Mohammad Reza Deevband, Mahasti Amoui, Ahmad Mostaar, Mahdi Ghorbani, Mohsen Khosroabadi, Mohammad Ali Ghodsirad

    Published 2025-01-01
    “…Materials and Methods: The filtered back-projection reconstruction method was used in neuro-endocrine tumor scanning using 177Lu-DOTATATE. Three hours after injection of 177Lu-DOTATATE, SPECT scans from 177Lu-DOTATATE for 30 patients were acquired using a dual-head EvoExel detector system. …”
    Get full text
    Article
  14. 1474

    Measuring Response to Therapy by Near-Infrared Imaging of Tumors Using a Phosphatidylserine-Targeting Antibody Fragment by Jian Gong, Richard Archer, Michael Brown, Seth Fisher, Connie Chang, Matthew Peacock, Christopher Hughes, Bruce Freimark

    Published 2013-06-01
    “…Imaging tumors and their response to treatment could be a valuable biomarker toward early assessment of therapy in patients with cancer. …”
    Get full text
    Article
  15. 1475

    Role of hypothalamic-pituitary-adrenal axis and catecholamine factors in independent and primary multiple types of tumor growth by E. M. Frantsiyants, V. A. Bandovkina, I. V. Kaplieva, E. I. Surikova, Yu. A. Pogorelova, N. D. Cheryarina, L. K. Trepitaki, I. V. Neskubina, A. A. Vereskunova, I. M. Kotieva, K. A. Shumarin, A. I. Shikhlyarova, I. V. Goroshinskaya

    Published 2022-12-01
    “…Statistical processing of results was performed using the Statistica 10.0 program.Results. All tumor-bearing females showed elevated corticotropin releasing in the hypothalamus together with an increase of all stress-characterizing parameters: cortisol, the cortisol/DHEA-S ratio, and noradrenaline. …”
    Get full text
    Article
  16. 1476

    Influencia del estadio tumoral inicial en la sobrevida de pacientes con adenocarcinoma renal by Jorge Luis Darias Martín, Tomás Lázaro Rodríguez Collar

    Published 2018-01-01
    “… Introducción: el adenocarcinoma renal representa hasta el 80 % de los tumores sólidos de este órgano, además de ser el de peor pronóstico. …”
    Get full text
    Article
  17. 1477
  18. 1478

    Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population by Anthony S. Perry, Bungo Furusato, Raymond B. Nagle, Sourav Ghosh

    Published 2014-01-01
    “…Additionally, aPKC staining levels correlated with Gleason score and tumor stage. Our results extend the association of aPKC with prostate cancer to a Japanese population and establish the suitability of aPKC as a universal prostate cancer biomarker that performs consistently across ethnicities.…”
    Get full text
    Article
  19. 1479

    Early Esophageal Cancer Specific Survival Is Unaffected by Anatomical Location of Tumor: A Population-Based Study by Rajan N. Amin, Samip J. Parikh, Venu Gopala Reddy Gangireddy, Praveen Kanneganti, Swathi Talla, Sumanth Daram

    Published 2016-01-01
    “…Tumors located in lower third had better 5-year survival compared to those located in middle third (83.50% versus 73.10%, p<0.01). …”
    Get full text
    Article
  20. 1480

    KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer by Kaiyu Shen, Binyu Chen, Liu Yang, Wencang Gao

    Published 2023-01-01
    “…Kynureninase (KYNU) is a potential prognostic marker for various tumor types. However, no reports on the biological effects and prognostic value of KYNU in gastric cancer (GC) exist. …”
    Get full text
    Article